PL444904A1 - Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych - Google Patents
Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnychInfo
- Publication number
- PL444904A1 PL444904A1 PL444904A PL44490423A PL444904A1 PL 444904 A1 PL444904 A1 PL 444904A1 PL 444904 A PL444904 A PL 444904A PL 44490423 A PL44490423 A PL 44490423A PL 444904 A1 PL444904 A1 PL 444904A1
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- sulfanylpyridine
- conjugated
- dimethyl
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pierwszym przedmiotem zgłoszenia jest nowa pochodna 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, przedstawiona wzorem ogólnym (I). Ponadto, wynalazek obejmuje sposób otrzymywania nowej pochodnej 4 o wzorze ogólnym (I), jej zastosowanie do leczenia chorób nowotworowych oraz do otrzymywania kompozycji leczniczych.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL444904A PL248780B1 (pl) | 2023-05-15 | 2023-05-15 | Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL444904A PL248780B1 (pl) | 2023-05-15 | 2023-05-15 | Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL444904A1 true PL444904A1 (pl) | 2024-11-18 |
| PL248780B1 PL248780B1 (pl) | 2026-01-26 |
Family
ID=93522705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL444904A PL248780B1 (pl) | 2023-05-15 | 2023-05-15 | Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL248780B1 (pl) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004096781A1 (en) * | 2003-04-25 | 2004-11-11 | Astrazeneca Ab | Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo) |
| WO2005039569A1 (en) * | 2003-10-18 | 2005-05-06 | Bayer Healthcare Ag | 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| US20060100235A1 (en) * | 2003-04-11 | 2006-05-11 | Novo Nordisk A/S | Pharmaceutical use of substituted 1,2,4-triazoles |
-
2023
- 2023-05-15 PL PL444904A patent/PL248780B1/pl unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060100235A1 (en) * | 2003-04-11 | 2006-05-11 | Novo Nordisk A/S | Pharmaceutical use of substituted 1,2,4-triazoles |
| WO2004096781A1 (en) * | 2003-04-25 | 2004-11-11 | Astrazeneca Ab | Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo) |
| WO2005039569A1 (en) * | 2003-10-18 | 2005-05-06 | Bayer Healthcare Ag | 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
Non-Patent Citations (1)
| Title |
|---|
| MOHAMMED B. WATHIQ AL-TAMIMI.: "International Journal of Health Sciences, August 2022, 7185-7203", SYNTHESIS, IDENTIFICATION OF SOME NEW 1,2,4-TRIAZOLE DERIVATIVES FROM 6-AMINO-1,3-DIMETHYLURACIL AND EVALUATION OF THEIR MOLECULAR DOCKING, ANTI-OXIDANT AND EXPERIMENTAL * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL248780B1 (pl) | 2026-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEAP202416530A (en) | Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof | |
| AR130425A1 (es) | Inhibidores de kras(g12d) | |
| ZA202405986B (en) | Nlrp3 inflammasome inhibitor and uses thereof | |
| MX2020007947A (es) | Inhibidores de erbb/btk. | |
| MX2024001331A (es) | Regulador derivado del cicloalqueno, método de preparación de este y su aplicación. | |
| MX2023000867A (es) | Inhibidor derivado de anillo fusionado que contiene nitrogeno, metodo de preparacion y uso del mismo. | |
| ES2164920T3 (es) | Nuevos derivados heterociclicos y uso medicinal de los mismos. | |
| MX2025007434A (es) | Compuesto con anillo fusionado de pirazol, metodo de preparacion y uso del mismo | |
| CR7743A (es) | Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf) | |
| JOP20240187A1 (ar) | مُعدِّلات الإنترلوكين-17a (il-17a) القائم على ثنائي-بروبيل حلقي واستخداماته | |
| MX2025010357A (es) | Degradador de irak4, y uso del mismo | |
| CA3200722A1 (en) | Heteroaryl-acetylenes, pharmaceutical compositions thereof, and their therapeutic applications | |
| ZA202501471B (en) | Preparation and use of quinazolinone derivative as kinase inhibitor | |
| WO2023102162A8 (en) | Novel hdac inhibitors and therapeutic use thereof | |
| MX2025001198A (es) | Composicion del inhibidor de irak4, metodo de preparacion y uso de este | |
| CO2022001513A2 (es) | Proceso e intermediarios para la preparación de piroxasulfona | |
| SA522441650B1 (ar) | مثبطات فوسفوينوسيتيد 3-كيناز الموضعية | |
| MX2025006152A (es) | Inhibidor polipeptidico, metodo de preparacion del mismo y uso del mismo | |
| MX2024008008A (es) | Derivado triciclico inhibidor, metodo de preparacion de este y aplicacion de este. | |
| GEAP202516765A (en) | Exatecan-derived adc linker-payloads, pharmaceutical compositions, and uses thereof | |
| CR20240203A (es) | Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2 | |
| CO2024010803A2 (es) | Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico | |
| MX2025012370A (es) | Compuesto de amida, composicion farmaceutica que comprende el compuesto y uso de esta | |
| PL444904A1 (pl) | Nowe pochodne 4,6-dimetylo-2-sulfanylopirydyny sprzężone z pierścieniem 1,2,4-triazolu, sposób syntezy pochodnych oraz zastosowanie pochodnych | |
| ZA202203360B (en) | Peptide amide composition and preparation method therefor |